Chief Scientific Officer (4) · RHYTHM PHARMACEUTICALS, INC. (RYTM)

Lex Van der Ploeg

FY2018 is the first fiscal year CompBrief holds for Lex Van der Ploeg as a named executive officer of RHYTHM PHARMACEUTICALS; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$1,397,205

Salary $383,361Stock awards $0

3rd of 3 named executive officers at Rhythm Pharmaceuticals by FY2018 total.

3 named officers on file for RHYTHM PHARMACEUTICALS, FY2018

Lex Van der Ploeg’s pay file — $29

  • 1 fiscal year of pay, line by line
  • RYTM’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how RHYTHM PHARMACEUTICALS’s whole pay program stands against its peers

  • RHYTHM PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on RYTM→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2019 (DEF 14A).

Free

Get Lex Van der Ploeg’s full pay file as a PDF — free

More than this page: up to 10 years of Lex’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Lex Van der Ploeg compensation by year

RHYTHM PHARMACEUTICALS Summary Compensation Table · the one fiscal year held
In US dollars, as RHYTHM PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018
Salary$383,361
Bonus$0
Stock awards$0
Option awards$866,250
Non-equity incentive$147,594
Pension and deferred compensation$0
All other$0
Total$1,397,205

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: RHYTHM PHARMACEUTICALS, INC. DEF 14A filed April 30, 2019, accession 0001047469-19-002750, and prior-year filings. Open the filing on EDGAR.

How this page was built: the RHYTHM PHARMACEUTICALS, INC. filed document, accession 0001047469-19-002750. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2019.

RHYTHM PHARMACEUTICALS’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Keith GottesdienerFormer President and Chief Executive Officer$3,539,804
Hunter SmithChief Financial Officer$1,587,137
Lex Van der Ploeg · this pageChief Scientific Officer (4)$1,397,205

The full RHYTHM PHARMACEUTICALS compensation record

free company brief

This page is one person within RHYTHM PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the RHYTHM PHARMACEUTICALS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are RHYTHM PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Lex Van der Ploeg's compensation dossier · One-time report. No refunds.